Comprehensive genomic studies: Emerging regulatory, strategic, and quality assurance challenges for biorepositories

American Journal of Clinical Pathology

Volumn 138, Issue 1, 2012, Pages 31-41

  McDonald, Sandra A ^a   Mardis, Elaine R ^b   Ota, David ^c   Watson, Mark A ^a   Pfeifer, John D ^a   Green, Jonathan M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biobanks; Biorepositories; Genomic studies; Quality assurance; Regulatory standards

Indexed keywords

CLINICAL DATA REPOSITORY; CLINICAL PRACTICE; GENETIC ANALYSIS; GENOMICS; HUMAN; INFORMED CONSENT; INSTITUTIONAL REVIEW; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SOLID TUMOR;

BIOLOGICAL SPECIMEN BANKS; ETHICS COMMITTEES, RESEARCH; GENETIC RESEARCH; GENOMICS; HUMANS; INFORMATION DISSEMINATION; QUALITY ASSURANCE, HEALTH CARE;

EID: 84864239558     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPXBA69LNSCVMH     Document Type: Review

References (37)

1. Mardis ER. A decade's perspective on DNA sequencing technology. Nature. 2011;470:198-203.
2. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009;461:272-276.
3. Teer JK, Mullikin JC. Exome sequencing: the sweet spot before whole genomes. Hum Mol Genet. 2010;19:R145-R151.
4. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087-1093.
5. Thomas G, Jacobs KB, Kraft P, et al. A multistage genomewide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41:579-584.
6. Zheng W, Long J, Gao YT, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41:324-328.
7. Morin RD, Bainbridge M, Fejes A, et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques. 2008:45:81-94.
8. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456:66-72.
9. Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A. 2004;101:13306-13311. (Pubitemid 39209661)
10. Homer N, Szelinger S, Redman M, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet. 4:e1000167. doi:10.1371/journal.pgen. 1000167.
11. The Pharmacogenomics Working Group: Terminology for sample collection in clinical genetic studies. Pharmacogenomics J. 2001;1:101-103.
12. McGuire AL, Caulfield T, Cho MK. Research ethics and the challenge of whole genome sequencing. Nat Rev Genet. 2009;9:152-156. (Pubitemid 351147709)
13. Pub L No. 110-233, 122 Stat 881.
14. Kaye J, Heeney C, Hawkins N, et al. Data sharing in genomics: re-shaping scientific practice. Nat Rev Genet. 2009;10:331-335.
15. Lunshof JE, Chadwick R, Vorhaus DB, et al. From genetic privacy to open consent. Nat Rev Genet. 2008;9:406-411. (Pubitemid 351556065)
16. Mardis ER. New strategies and emerging technologies for massively parallel sequencing: applications in medical research. Genome Med. 2009;1:40. doi:10.1186/gm40.
17. Walter MJ, Ding L, Shao J, et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia. 2011;25:1153-1158.
18. Ding L, Ellis MJ, Li S, et al. Genome remodeling in a basal-like breast cancer metastasis and xenograft. Nature. 2010;464:999-1005.
19. Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services. NCI Best Practices for Biospecimen Repositories, 2011 revised version. http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf. Accessed November 28, 2011.
20. International Society for Biological and Environmental Repositories (ISBER). 2008 Best Practices for Biorepositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. http://www.isber.org/bp/ BestPractices2008.pdf. Accessed November 28, 2011.
21. Department of Health, Education, and Welfare. Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research: Report of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. http://www.hhs.gov/ ohrp/archive/documents/ 19790418.pdf. Accessed December 13, 2011.
22. Department of Health and Human Services. Guidance on research involving coded private information or biological specimens. 2008. http://www.hhs.gov/ ohrp/policy/cdebiol. html. Accessed October 31, 2011.
23. McDonald SA, Chernock RD, Leach TA, et al. Procurement of human tissues for research banking in the surgical pathology laboratory: prioritization practices at Washington University Medical Center. Biopreserv Biobank. 2011;9:245-251.
24. NIH Points to Consider for IRBs and Institutions in Their Review of Data Submission Plans for Institutional Certifications Under NIH's Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies (GWAS). http://gwas.nih.gov/pdf/ GWAS-points-to-consider-A.pdf. Accessed October 28, 2011.
25. National Cancer Institute. TCGA Tissue Sample Requirements: High Quality Requirements Yield High Quality Data. The Cancer Genome Atlas. http:// cancergenome.nih.gov/cancersselected/biospeccriteria. Accessed January 4, 2012.
26. McDonald SA. Principles of research tissue banking and specimen evaluation from the pathologist's perspective. Biopreserv Biobank. 2010;8:197-201.
27. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001. (Pubitemid 26398425)
28. Williams C, Ponten F, Moberg C, et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol. 1999;155:1467-1471.
29. Kerick M, Timmermann B, Schweiger MR. High-throughput sequencing of frozen and paraffin-embedded tumor and normal tissue [in German]. Pathologe. 2010;31(suppl 2):255-257.
30. Duncavage EJ, Magrini V, Becker N, et al. Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. J Mol Diagn. 2011;13:325-333.
31. Green ED, Guyer MS; and the National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470:204-213. doi:10.1038/nature09764.
32. ZR Genomic DNA-Tissue MiniPrep. Zymo Research Web site. http://www.zymoresearch.com/dna-purification/ genomic-dna/blood-body-fluid-dna/ zymobead-genomicdna-kit. Accessed May 19, 2012.
33. Sample Preparation and Isolation of RNA or DNA. AsuraGen Web site. http://www.asuragen.com/Services/ services/sample-prep/fresh-frozen-tissues. aspx. Accessed November 29, 2011.
34. Average RNA yields typically obtained from various starting material. MACS molecular Web site. http://www. miltenyibiotec.com/download/further- information-en/836/ Average-RNA-yields.pdf. Accessed November 29, 2011.
35. Mychaleckyj JC, Farber EA, Chmielewski J, et al. Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long term storage. J Transl Med. 2011;9:91. doi:10.1186/1479-5876-9-91.
36. Voelkerding KV, Dames S, Durtschi JD. Next generation sequencing for clinical diagnostics: principles and application to targeted resequencing for hypertrophic cardiomyopathy. J Mol Diagn. 2010;12:539-551.
37. Metzker ML. Sequencing technologies: the next generation. Nat Rev Genet. 2010;11:31-46.